Yeeran

  • HOME

  • ABOUT US

    • Company Profile

    • History

    • Corporate Culture

  • NEWS

    • Events&Conference

    • Installation Training

    • Company News

  • PRODUCTS

    • Optical imaging

    • Pre-clinical imaging

    • Accessories

  • RESOURCES

    • Publications Library

    • Video

  • PARTNERS

  • CONTACT

Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress

2023-10-23

Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress


Automatic Respiratory Gating Hepatic DCEUS-based Dual-phase Multi-parametric Functional Perfusion Imaging using a Derivative Principal Component Analysis

2023-10-23

Automatic Respiratory Gating Hepatic DCEUS-based Dual-phase Multi-parametric Functional Perfusion Imaging using a Derivative Principal Component Analysis


iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway

2023-10-23

iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway


Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway

2023-10-23

Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway


iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation

2023-10-23

iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation


Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries

2023-10-23

Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries


1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy

2023-10-23

1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy


V1-Cal hydrogelation enhances its effects on ventricular remodeling reduction and cardiac function improvement post myocardial infarction

2023-10-23

V1-Cal hydrogelation enhances its effects on ventricular remodeling reduction and cardiac function improvement post myocardial infarction


< 123 >
  • HOME

  • ABOUT US

    • Company Profile

    • History

    • Corporate Culture

  • NEWS

    • Events&Conference

    • Installation Training

    • Company News

  • PRODUCTS

    • Optical imaging

    • Pre-clinical imaging

    • Accessories

  • RESOURCES

    • Publications Library

    • Video

  • PARTNERS

  • CONTACT

Provider of overall solution

Yeeran
Yeeran
Yeeran
Yeeran

Contact Us

daisypeng@yeeranchina.net

ADD:Room b02-2915, no.10 fuli canal, tongzhou district, Beijing, China
Postal Code:101100
Tel :+86-010-69549099


 Copyright © Beijing Yeeran Technology Co,Ltd.   Powered by 300.cn  SEO   Business license